A review looks at techniques to monitor minimal residual disease (MRD) in patients with multiple myeloma (MM). “In most patients, the cause of the relapse is residual drug-resistant MM cells,” the ...
A recent review outlined advances and challenges in utilizing liquid biopsy to detect measures such as circulating tumor DNA in patients with solid tumors. MRD refers to the presence of residual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback